期刊文献+

马栗种子提取物治疗黄斑水肿临床观察

The Clinical Effect of Oral the Horse Chestnut Seed Extract for Treating Macular Edema
下载PDF
导出
摘要 目的:观察口服马栗种子提取物治疗黄斑水肿的临床疗效。方法:将50例黄斑水肿患者60眼随机分为两组,对照组采用常规促吸收疗法(口服维生素C、E和芦丁片),治疗组在常规治疗基础上加用马栗种子提取物口服,4周为1个疗程,观察3个疗程。分别于治疗后4周和12周进行Amsler表、最佳矫正视力(Best corrected visual acuity,BCVA)、FFA及OCT检查并评分定性判定治疗效果。结果:治疗后4周,治疗组有效率80.6%,对照组有效率25.0%,两组相比差异有显著统计学意义(P<0.01)。两组治疗后12周,治疗组有效率86.1%,对照组有效率33.3%,两组相比差异有显著统计学意义(P<0.01)。两组在治疗观察期间均未发现不良反应。结论:马栗种子提取物可以安全有效的缓解黄斑水肿,改善视功能。 Objective:To observe the clinical efficacy of oral the horse chestnut seed extract for treating macular edema. Methods:Fifty cases of macular edema patients(sixty eyes)were randomly divided into 2 groups. The conventional therapy(oral vitamin C,E and Rutin tablets)was used in control group. The treatment group was treated with oral horse chestnut seed extract and conventional therapy. Amsler's chart,best corrected visual acuity,FFA and OCT were examined 4 wk and 12 wk post-treatment. Results:After 4 weeks and 12 weeks observation,the effective rates in treatment group were better than those in the control group(80.6% vs 25.0%;86.1% vs 33.3%),the difference was significant(P0.01),no adverse reactions was observed in treatment group. Conclusion:The horse chestnut seed extract is effective in relieving macular edema and improving visual function with no adverse reactions.
作者 刘蕾 崔丽红
出处 《辽宁中医药大学学报》 CAS 2015年第3期160-162,共3页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 马栗种子提取物 黄斑水肿 视功能 the horse chestnut seed extract macular edema visual function
  • 相关文献

参考文献10

二级参考文献37

  • 1齐慧君,黎晓新.糖尿病性黄斑水肿的激光治疗[J].眼科,2005,14(4):234-236. 被引量:35
  • 2郭彤,张惠蓉.氩激光和氪激光治疗糖尿病性黄斑水肿疗效的比较[J].中国实用眼科杂志,2006,24(2):142-144. 被引量:8
  • 3王延武,张弛.多波长氪离子激光治疗糖尿病性黄斑水肿[J].中国激光医学杂志,2007,16(2):123-124. 被引量:2
  • 4郭学利,王子凡,宋燕.威利坦治疗下肢慢性静脉功能不全临床研究[J].医药论坛杂志,2007,28(7):24-25. 被引量:11
  • 5Tso MOM. Retinal photocoagulation therapy: Clinical application and biological basis of therapeutic effects. In: Tso MOM(ed). Retinal Diseases. Philadelphia: J B Lippincott Company, 1988: 246-262.
  • 6Sivaprasad S, Saudhu R, Tandon A, et al. Subthreshold mincropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-years follow-up. Clin Experiment Ophthalmol, 2007, 35: 640-644.
  • 7Hitani K, Yamamoto T, Sato Y. Long-term results of grid pattern photocoagulation for diffuse diabetic maeular edema. Nippon Ganka Gakkai Zasshi, 2007, 111: 401-406.
  • 8Higuchi A, Ogata N, Io N, et al: Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Jpn J Ophthalmol, 2006, 50:529-531.
  • 9Ng EW, Adamis AP. Anti-VEGF aptamer(pegaptanib) therapy for ocular vascular diseases. Ann N Y Acad Sci, 2006, 1082: 151-157.
  • 10Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (avastin) therapy for persistent diffuse diabetic macular edema. Retina, 2006, 26:999-1005.

共引文献186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部